Conquering cancer is too daunting for any one discipline, approach, or individual. It requires melding the insights from multiple disciplines – cancer biology, chemistry,... | [more]
Welcome to Dana-Farber/Harvard Cancer Center
Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Children's Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.
Announcements
- 1/31 Seminars in Oncology: "Toward Deciphering the Genetic Landscape in Melanoma" Posted: 01-25-12
- Feb 1 deadline - Letter of Intent due for U54 Grant Applications Posted: 01-23-12
- Request for Applications: Pilot Grants for Child Health Research Posted: 01-19-12
Latest Cancer News
Cancer Cell Biology Program: Matchmaker to Interdisciplinary Researchers
Translating disease-related findings
While John Blenis, PhD (HMS), a cell biologist and biochemist interested in cancer cell metabolism, works at the basic science level, he collaborates with pre-clinical... | [more]
Cell Manipulation Core Facility
The Cell Manipulation Core Facility (CMCF) produces safe and effective cellular components for subjects enrolled in novel therapeutic clinical research protocols. The... | [more]
